These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

45 related articles for article (PubMed ID: 5524277)

  • 21. Laminin alpha1 chain in human renal cell carcinomas and integrin-mediated adhesion of renal cell carcinoma cells to human laminin isoforms.
    Rissanen J; Korhonen M; Lehto VP; Virtanen I
    J Pathol; 2003 Jun; 200(2):157-67. PubMed ID: 12754736
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Claudin-1 protein expression is a prognostic marker of patient survival in renal cell carcinomas.
    Fritzsche FR; Oelrich B; Johannsen M; Kristiansen I; Moch H; Jung K; Kristiansen G
    Clin Cancer Res; 2008 Nov; 14(21):7035-42. PubMed ID: 18981000
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Expression of bcl-2 oncoprotein in renal cell tumours.
    Paraf F; Gogusev J; Chrétien Y; Droz D
    J Pathol; 1995 Nov; 177(3):247-52. PubMed ID: 8551386
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Ex vivo stimulation of renal transport of the cytostatic drugs methotrexate, cisplatin, topotecan (Hycamtin) and raltitrexed (Tomudex) by dexamethasone, T3 and EGF in intact human and rat kidney tissue and in human renal cell carcinoma.
    Fleck C; Hilger R; Jurkutat S; Karge E; Merkel U; Schimske A; Schubert J
    Urol Res; 2002 Sep; 30(4):256-62. PubMed ID: 12202944
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Tumor-specific lysis of human renal cell carcinomas by tumor-infiltrating lymphocytes: modulation of recognition through retroviral transduction of tumor cells with interleukin 2 complementary DNA and exogenous alpha interferon treatment.
    Schendel DJ; Gansbacher B
    Cancer Res; 1993 Sep; 53(17):4020-5. PubMed ID: 8358731
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Parvalbumin is constantly expressed in chromophobe renal carcinoma.
    Martignoni G; Pea M; Chilosi M; Brunelli M; Scarpa A; Colato C; Tardanico R; Zamboni G; Bonetti F
    Mod Pathol; 2001 Aug; 14(8):760-7. PubMed ID: 11504835
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Influence of dietary protein deficiency on intestinal absorption and on the tissue distribution of absorbed Fe59 in male rats. Effects of erythropoietin injections].
    Aschkenasy A
    Rev Fr Etud Clin Biol; 1966 Dec; 11(10):1010-22. PubMed ID: 5979828
    [No Abstract]   [Full Text] [Related]  

  • 28. New human renal carcinoma cell line established from a patient with erythrocytosis.
    Sytkowski AJ; Richie JP; Bicknell KA
    Cancer Res; 1983 Mar; 43(3):1415-9. PubMed ID: 6825111
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Bioassay of erythropoietin using foetal mouse liver cells.
    Wardle DF; Malpas JS; Wrigley PF
    Br J Haematol; 1973 Jan; 24(1):49-56. PubMed ID: 4715137
    [No Abstract]   [Full Text] [Related]  

  • 30. Decreased responsiveness of hematopoietic tissue to erythropoietin in acutely uremic rats.
    Bozzini CE; Devoto FC; Tomio JM
    J Lab Clin Med; 1966 Sep; 68(3):411-7. PubMed ID: 5922752
    [No Abstract]   [Full Text] [Related]  

  • 31. A factor from urine which modulates in vivo erythropoietin activity.
    Dukes PP; Ortega JA; Shore NA; Harris K; Polk C
    Haematologica; 1978 Aug; 63(4):420-5. PubMed ID: 100384
    [No Abstract]   [Full Text] [Related]  

  • 32. The chemistry and physiology of erythropoietin.
    Sherwood JB
    Vitam Horm; 1984; 41():161-211. PubMed ID: 6397910
    [No Abstract]   [Full Text] [Related]  

  • 33. [A case of erythropoietin-producing renal cell carcinoma with polycythemia].
    Okuyama M; Nishihara M; Hashimoto H; Kaneko S; Yachiku S
    Hinyokika Kiyo; 2002 Sep; 48(9):531-4. PubMed ID: 12402477
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Activity of PDGF (A) gene in the human cell line derived from a renal carcinoma metastasis.
    Sovová V; Sloncová E; Damková M; Vydra J; Jakoubková J
    Folia Biol (Praha); 1993; 39(1):40-6. PubMed ID: 8348984
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Responsiveness to exogenous erythropoietin in tissue culture fluid of human renal cell carcinomas.
    Murphy GP; Brendler H; Mirand EA
    Res Commun Chem Pathol Pharmacol; 1970 Nov; 1(6):761-8. PubMed ID: 5524277
    [No Abstract]   [Full Text] [Related]  

  • 36. Erythropoietin release from renal cell carcinomas grown in tissue culture.
    Murphy GP; Brendler H; Mirand EA
    Res Commun Chem Pathol Pharmacol; 1970 Sep; 1(5):617-26. PubMed ID: 5524267
    [No Abstract]   [Full Text] [Related]  

  • 37. Erythropoietin production by human renal carcinoma cells in culture.
    Sherwood JB; Goldwasser E
    Endocrinology; 1976 Aug; 99(2):504-10. PubMed ID: 986292
    [TBL] [Abstract][Full Text] [Related]  

  • 38.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 39.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.